G-CSF is considered a relatively safe treatment that can rarely cause hypersensitivity reactions, ranging from low-risk, cutaneous eruptions to anaphylaxis and even delayed reactions mostly defined as maculopapular exanthemas. Here, CSF3 is linked to anaphylaxis.